Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation
Completed
- Conditions
- Acute Coronary Syndrome
- Interventions
- Diagnostic Test: Flow Cytrometry; Thrombin Generation Assay
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- CirQuest Labs, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT03746782
- Locations
- 🇺🇸
CirQuest Labs, LLC, Memphis, Tennessee, United States
Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease
- Conditions
- Coronary Artery DiseaseHeart Failure With Reduced Ejection Fraction
- Interventions
- Other: Biomarker Assessment
- First Posted Date
- 2018-06-11
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- CirQuest Labs, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT03551756
- Locations
- 🇺🇸
University of Florida, Jacksonville, Florida, United States
🇺🇸Stern Cardiovascular, Germantown, Tennessee, United States
🇺🇸CirQuest Labs, LLC, Memphis, Tennessee, United States
A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- CirQuest Labs, LLC
- Registration Number
- NCT03027934
© Copyright 2025. All Rights Reserved by MedPath